Joel Greenblatt's TMDX Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 40,872 shares of TransMedics Group, Inc. (TMDX) worth $4.97 M, representing 0.02% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in TMDX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 32,635 shares. Largest reduction occurred in Q3 2023, reducing 18,727 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's TransMedics Group (TMDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly TransMedics Group (TMDX) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +32,635 | Add 396.20% | 40,872 | $121.65 |
| Q3 2025 | +5,078 | Add 160.75% | 8,237 | $112.20 |
| Q2 2025 | +3,159 | New Buy | 3,159 | $134.01 |
| Q3 2024 | -1,993 | Sold Out | 0 | $0.00 |
| Q2 2024 | +1,993 | New Buy | 1,993 | $150.62 |
| Q3 2023 | -18,727 | Sold Out | 0 | $0.00 |
| Q2 2023 | -10,532 | Reduce 36.00% | 18,727 | $83.98 |
| Q1 2023 | +12,242 | Add 71.94% | 29,259 | $75.73 |
| Q4 2022 | +17,017 | New Buy | 17,017 | $61.72 |
Joel Greenblatt's TransMedics Group Investment FAQs
Joel Greenblatt first purchased TransMedics Group, Inc. (TMDX) in Q4 2022, acquiring 17,017 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held TransMedics Group, Inc. (TMDX) for 9 quarters since Q4 2022.
Joel Greenblatt's largest addition to TransMedics Group, Inc. (TMDX) was in Q4 2025, adding 40,872 shares worth $4.97 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 40,872 shares of TransMedics Group, Inc. (TMDX), valued at approximately $4.97 M.
As of the Q4 2025 filing, TransMedics Group, Inc. (TMDX) represents approximately 0.02% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in TransMedics Group, Inc. (TMDX) was 40,872 shares, as reported at the end of Q4 2025.